Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4518_Библиотеки_им_академика_М_И_Перельмана
.pdf
12 Head andNeck Pathology
https://t.me/medicina_free
Fig. 12.64 Grave’s disease: hyperplastic papillary thyroid epithelium. Scalloping of colloid (arrow)
259
• Cyst lined by squamous or respiratory epithelium.
• Presence of thyroid tissue variably reported (25–60%).
• Thyroid tissue may exhibit nodules, hyperplasia, or rarely neoplasia.
Graves’ Disease (Diffuse Hyperplasia) (Fig.12.64)
• Diffuse toxic form of goiter; autoimmune hyperthyroidism
• Hyperplasia affecting entire gland, formation of simple papillary projections
observed
• Scalloping phenomenon of colloid (small vacuoles) but colloid may be absent
• Lymphocytic inltration not uncommon
• Ophthalmopathy:
– Accumulation of chronic inammatory cells, edema, and glycosaminogly-
cans in extraocular muscles and contributes to proptosis
Multinodular Goiter (Fig.12.65)
• Adenomatoid nodules with cystic degeneration.
• Enlarged follicles with abundance of colloid.
• Papillary fronds that extend into irregular thyroid follicles.
• No compression of surrounding gland, poor or no encapsulation of nodules.
• Cells comprising nodule have similar morphology to cells adjacent to nodule.
Amyloid Goiter (Fig.12.66)
• Thyroid enlargement secondary to intercellular amyloid deposition
• Pale, eosinophilic, acellular, amorphous material with peculiar “cracking”
artifact
• Can accumulate around blood vessels
• Minimal normal thyroid tissue remains, amyloid overtakes gland in systemic
amyloidosis

260
https://t.me/medicina_free
Fig. 12.65 Multinodular goiter: low magnication view of multinodular appearance
C. J. Fan et al.
Fig. 12.66 Amyloid goiter: acellular, eosinophilic amyloid. Present around blood vessel
• May see focal amyloid deposition in association with medullary thyroid
carcinoma
• Special stains:
– Congo red stain shows apple green birefringence under polarized light.
– Crystal violet: amyloid metachromatic.
– Thioavin T positive.
Hashimoto’s Thyroiditis (Fig.12.67)
• Autoimmune disease associated with enlargement of thyroid and eventual
hypothyroidism
• Advanced: similar to Riedel’s thyroiditis (extensive brosis) but localized to
the thyroid

12 Head andNeck Pathology
https://t.me/medicina_free
Fig. 12.67 Hashimoto’s thyroiditis: thyroid tissue with marked inammation and germinal center
formation
261
Fig. 12.68 Follicular adenoma: encapsulated, cellular benign thyroid neoplasm. The tumor has a
complete thin capsule and shows a growth pattern distinct from that of the adjacent normal thyroid
• Lymphocytic thyroiditis: inltration with germinal center formation
• Follicular acinar atrophy, degenerative phenomenon, decreased colloid
• Hurthle cell metaplasia: oxyphilic/oncocytic cells, extensive eosinophilia, large
polygonal follicular cells with granular cytoplasm
Follicular Adenoma (Fig.12.68)
• Benign, encapsulated, noninvasive neoplasm with thyroid follicular cell
differentiation.
• Adenoma cells different from normal gland: more cellular, +/− larger follicles.

262
https://t.me/medicina_free
C. J. Fan et al.
• Normal thyroid gland adjacent to adenoma may appear compressed.
• Well-dened capsule present around adenoma, no capsular invasion, no vascular
invasion.
• Architectural and cytological features of tumor different from surrounding
thyroid.
• Uniform small round nuclei and nuclear atypia may be seen.
• Hurthle cell/oxyphilic cells can be present.
• Stroma component is scant but can be edematous, hyalinized, or mucin-like.
• Secondary changes like cystic degeneration, calcication, and osseous metaplasia possible.
Follicular Carcinoma (Fig.12.69)
• Malignancy arising from thyroid follicular cells and absent papillary thyroid
carcinoma-nuclear features.
• RAS family mutations are found in 30–50% of tumors.
• Diagnosis requires identication of capsular and/or vascular invasion.
• Three subtypes:
– Minimally invasive (capsular invasion only)
– Encapsulated angioinvasive
– Widely invasive
• Variable microscopic patterns of tumor cells (solid, trabecular, microfollicles).
• Signicant morphologic overlap with benign follicular adenoma.
• Hurthle cell subtype/oxyphilic type may have limited colloid.
• Most reliable indication of malignancy: capsular and/or vascular invasion.
Neoplastic cells penetrate the entire thickness of the tumor capsule to qualify
for capsular invasion.
Fig. 12.69 Follicular carcinoma: capsular invasion by malignant thyroid neoplasm (arrows)

a
12 Head andNeck Pathology
https://t.me/medicina_free
263
Papillary Thyroid Carcinoma (Fig.12.70)
• Malignant epithelial tumor with follicular cell differentiation
• Cardinal features: Formation of papillae and unique nuclear features
– Papillae: neoplastic epithelial cells surface a central brovascular stalk
• Psammoma body: Laminated microcalcication common in classic, tall cell
and hobnail
b c
Fig. 12.70 Papillary thyroid carcinoma: (a) Papillary architecture of malignant neoplasm. (b)
Nuclear pseudoinclusion (long arrow) and nuclear groove (short arrow). (c) Concentric lamination
of psammoma body

264
https://t.me/medicina_free
C. J. Fan et al.
– Thought to represent the presence of old, calcied tumor cells.
– Presence of psammoma body alone in the lymph node is indicative of meta-
static disease and considered pN1a by the College of American
Pathologists (2017).
• Select subtypes (includes conventional/classic):
– Classic: well-formed papillae, nuclear grooves, pseudo-inclusions, psam-
moma bodies
– Follicular variant: encapsulated, small follicles present, lacks architecture of
papillae, enlarged and pale nuclei, nuclear grooves, dense colloid
– Diffuse sclerosing variant: brosis, lymphocytic thyroiditis, psammoma bod-
ies, often involves the entire gland
– Tall cell variant: tall columnar cells present, tightly packed, nuclear grooves,
irregular nuclear membranes
– Columnar cell variant: columnar cells present, prominent papillae, parallel
follicles
– Unfavorable histologic forms: diffuse sclerosing, tall cell, columnar cell
variants
Medullary Thyroid Carcinoma (MTC) (Fig.12.71)
• Malignant thyroid neuroendocrine tumor arising from parafollicular C cells.
• Most MTC cases are sporadic (70–75%), with hereditary and syndromic forms
in 25–30%.
Fig. 12.71 Medullary thyroid carcinoma: Nests and ribbons of monotonous tumor cells with
nely stippled chromatin, brous bands (two arrows) and amyloid deposits (single arrow)

12 Head andNeck Pathology
https://t.me/medicina_free
265
– Most commonly encountered syndromes include:
MEN2A, MEN2B, and familial MTC (latter may be in spectrum
of MEN2A)
C-cell hyperplasia in inherited, with associated elevated calcitonin levels
Characterized by gain-of-function germline mutations in the RET
proto-oncogene
• Histologic appearance does not vary between sporadic and inherited MTC.
• Sporadic cases tend to be unifocal, familial cases multifocal and bilateral.
• Tumor cells organized into many patterns with lymphovascular invasion.
• Stippled “salt and pepper” nuclear chromatin present in individual cells.
• Amyloid present as amorphous pink material in stroma; Congo red stain and
polarized light shows apple green birefringence.
Anaplastic Carcinoma (Fig.12.72)
• High-grade thyroid malignancy composed of undifferentiated follicular thyroid cells
• May arise de novo or from high-grade transformation of a well-differentiated
carcinoma, usually a papillary thyroid carcinoma
• Necrosis, extensive extrathyroidal extension common and rapid
• Lymphovascular invasion usually present
• Signicant cell pleomorphism: markedly atypical spindle cell predominant and/
or giant cells with large hyperchromatic nuclei
• Must identify origin from thyroid, may appear to be a soft tissue sarcoma
Fig. 12.72 Anaplastic carcinoma: Sheet of pleomorphic tumor cells and giant cells and adjacent
necrosis (arrow)

266
https://t.me/medicina_free
C. J. Fan et al.
Parathyroid Gland (Fig.12.73)
• Chief cells: round nuclei, pale eosinophilic cytoplasm.
• Oxyphil cells: larger than chief cells, densely pink cytoplasm (oncocytic).
• Mature fat.
• Glands normally weigh 30–40mg each.
Parathyroid Hyperplasia (Fig.12.74)
• Non-neoplastic
• Most commonly results of hyperparathyroidism, but can be idiopathic
• Increased number of chief and oncocytic cells in multiple parathyroid glands,
with limited stromal fat
Fig. 12.73 Normal parathyroid: chief (pale), oxyphilic (densely pink), and mature adipose tissue
Fig. 12.74 Parathyroid hyperplasia showing a nodular proliferation of chief and oncocytic cells

12 Head andNeck Pathology
https://t.me/medicina_free
Fig. 12.75 Parathyroid adenoma: Demonstrates a rim of compressed normal tissue
267
Parathyroid Adenoma (Fig.12.75)
• Benign parathyroid neoplasm of chief oncocytic cells or an admixture.
• Can arise in normally situated or ectopic glands.
• 85% of cases with single, enlarged, hypercellular gland.
• 15% of patients with “double adenomas” show predilection for superior glands.
• Adenoma can be sporadic or occur in patients with genetic susceptibility.
• Genetic susceptibility: MEN1, MEN2A, CDC73-related disorders
(hyperparathyroidism- jaw tumor syndrome, familial isolated
hyperparathyroidism).
• Microscopically adenoma shows parenchymal cell proliferation (oncocytic/
chief cells).
• Usually gland enlarged, encapsulated, absence of intraparenchymal fat.
• May or may not have rim of compressed normal parathyroid tissue.
Parathyroid Carcinoma (Fig.12.76)
• Rare malignant neoplasm of parathyroid parenchymal cells.
• Majority of tumors are functional tumors (hypercalcemia,
hyperparathyroidism).
• Aggregate of microscopic and clinical features are supportive of diagnosis.
• Capsular, vascular, or perineural invasion (not commonly seen).
• Adherence or invasion of thyroid or other soft tissue extension.
• Formation of thick brous septae/bands.
• Metastasis.

268
https://t.me/medicina_free
Fig. 12.76 Parathyroid carcinoma: Trabeculae and islands of parathyroid carcinoma inltrating
the skeletal muscle
C. J. Fan et al.
Further Reading
1. Balakumar R, Farr MRB, Fernando M, etal. Adult-type rhabdomyoma of the larynx in BirtHogg- Dubé syndrome: evidence for a real association. Head Neck Pathol. 2019;13(3):507–11.
2. Benedict JJ, Derkay CS.Recurrent respiratory papillomatosis: a 2020 perspective. Laryngosc
Investig Otolaryngol. 2021;6(2):340–5.
3. Bradford CR, Ferlito A, Devaney KO, etal. Prognostic factors in laryngeal squamous cell
carcinoma. Laryngosc Investig Otolaryngol. 2020;5(1):74–81.
4. Rindi G, Klimstra DS, Abedi-Ardekani B, etal. A common classication framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World
Health Organization (WHO) expert consensus proposal. Mod Pathol. 2018;31(12):1770–86.
5. Grifth CC, Schmitt AC, Little JL, Magliocca KR. New developments in salivary gland
pathology: clinically useful ancillary testing and new potentially targetable molecular alterations. Arch Pathol Lab Med. 2017;141(3):381–95.
6. Grayson JW, Hopkins C, Mori E, Senior B, Harvey RJ.Contemporary classication of chronic
rhinosinusitis beyond polyps vs no polyps: a review. JAMA Otolaryngol Head Neck Surg.
2020;146(9):831–8.
7. Minni A, Gera R, Bulgheroni C, etal. Endoscopic resection of sinonasal inverted papilloma:
a multivariate retrospective analysis of factors affecting recurrence and persistence. Ear Nose
Throat J. 2019;100(5):542–8.
8. Lilja M, Viitasalo S, Hytönen M, etal. Sinonasal oncocytic papilloma-a series of 20 cases with
special emphasis on recurrences. Laryngosc Investig Otolaryngol. 2019;4(6):567–72.
9. Bracigliano A, etal. Sinonasal tumors: update on histological and clinical management. Curr
Oncol. 2021;28(4):2420–38.
10. Rooper LM, Agaimy A, Dickson BC, etal. DEK-AFF2 carcinoma of the sinonasal region and
skull base: detailed clinicopathologic characterization of a distinctive entity. Am J Surg Pathol.
2021;45(12):1682–93.
11. Castle JT. Cholesteatoma pearls: practical points and update. Head Neck Pathol.
2018;12(3):419–29.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
